🔎 Trials Near Me

Hjem › Lungekreft › Virginia › Richmond

Kliniske studier for Lungekreft i Richmond, VA

14 studier for Lungekreft søker deltakere på steder i og rundt Richmond (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RekruttererFase 3
  • Virginia Cancer Institute, Richmond
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Bon Secours Richmond Community Hospital, Richmond
  • Bon Secours Saint Mary's Hospital, Richmond
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond
  • og 3 flere
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

RekruttererFase 3
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
Alder 70 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06096844

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RekruttererFase 3
  • Virginia Cancer Institute, Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06498635

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

RekruttererFase 2/3
  • VCU Massey Cancer Center, Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06712316

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

RekruttererFase 2/3
  • Virginia Commonwealth University (Vcu), Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

RekruttererFase 1/2
  • VCU Massey Comprehensive Cancer Center, Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06287775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • VCU Health Adult Outpatient Pavillion, Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

The Vanguard Study: Testing a New Way to Screen for Cancer

RekruttererFrivillige helsepersonell ønskes velkommen
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
Alder 45 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06995898

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

RekruttererFase 3
  • Virginia Commonwealth University School of Medicine, Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06712355

Health Education Approach to Lung Screening

RekruttererFrivillige helsepersonell ønskes velkommen
  • Virginia Commonwealth University, Richmond
Alder 50 til 80 · Alle kjønn · Oppdatert 25. aug. 2026 · NCT06070870

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

RekruttererFase 2
  • VCU Medical Center (Virginia Commonwealth University), Richmond
Alder 18 til 70 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT04614103

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2/3
  • Virginia Cancer Institute, Richmond
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT06616584

Lungekreft-studier i andre byer

Andre studier i Richmond

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.